omeprazole has been researched along with lafutidine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inaba, N; Ohnishi, H; Onodera, S; Shibata, M; Tanaka, M; Yamaura, T | 1 |
| Mikawa, K; Morikawa, O; Nishina, K; Obara, H; Takao, Y; Uesugi, T | 1 |
| Furusu, H; Inoue, K; Isomoto, H; Kohno, S; Mizuta, Y; Murase, K; Murata, I; Nishiyama, H; Omagari, K; Shikuwa, S | 1 |
| Horikawa, Y; Inoue, M; Kuroiwa, T; Mieno, H; Nakamura, M; Shimatani, T | 1 |
| Abe, Y; Chiguchi, G; Inamori, M; Iwasaki, T; Kawamura, H; Kikuchi, T; Kirikoshi, H; Kobayashi, N; Kubota, K; Matsumoto, S; Muramatsu, K; Nakajima, A; Ozawa, Y; Saito, S; Sakaguchi, T; Shimamura, T; Togawa, J; Ueno, N | 1 |
| Kawano, S; Tsuji, S | 1 |
| Goso, Y; Ichikawa, T; Ikezawa, T; Ishihara, K; Iwai, T; Nakano, M; Saegusa, Y; Saigenji, K; Shikama, N | 1 |
| Amagase, K; Kato, S; Ochi, A; Sugihara, T; Takeuchi, K | 1 |
| Chang, YW; Choi, MG; Chun, HJ; Han, SW; Jeong, HY; Jung, HC; Jung, HY; Jung, JT; Kim, EH; Kim, HS; Kim, HY; Kim, JG; Lee, DH; Lee, OJ; Lee, ST; Lee, SW; Lee, YC; Park, JJ; Park, SH; Seol, SY; Youn, SJ | 1 |
5 trial(s) available for omeprazole and lafutidine
| Article | Year |
|---|---|
The efficacy of lafutidine in improving preoperative gastric fluid property: a comparison with ranitidine and rabeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Female; Gastric Acid; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Intraoperative Complications; Intubation, Gastrointestinal; Male; Middle Aged; Omeprazole; Piperidines; Preoperative Care; Proton Pump Inhibitors; Pyridines; Rabeprazole; Ranitidine; Risk Assessment; Stomach | 2002 |
Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Piperidines; Prospective Studies; Pyridines | 2003 |
Effect of omeprazole 10 mg on intragastric pH in three different CYP2C19 genotypes, compared with omeprazole 20 mg and lafutidine 20 mg, a new H2-receptor antagonist.
Topics: Acetamides; Adult; Aryl Hydrocarbon Hydroxylases; Circadian Rhythm; Cross-Over Studies; Cytochrome P-450 CYP2C19; Gastric Acid; Gastric Acidity Determination; Genotype; Humans; Hydrogen-Ion Concentration; Male; Manometry; Mixed Function Oxygenases; Omeprazole; Piperidines; Prospective Studies; Pyridines; Receptors, Histamine H2 | 2003 |
Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Administration, Oral; Adult; Benzimidazoles; Cross-Over Studies; Drug Administration Schedule; Gastric Acid; Gastric Acidity Determination; Heartburn; Humans; Hydrogen-Ion Concentration; Male; Monitoring, Physiologic; Omeprazole; Piperidines; Postprandial Period; Pyridines; Rabeprazole; Reference Values; Risk Assessment; Time Factors; Treatment Outcome | 2005 |
Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial.
Topics: Acetamides; Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Famotidine; Female; Humans; Male; Medication Adherence; Middle Aged; Omeprazole; Piperidines; Pyridines; Republic of Korea; Severity of Illness Index; Treatment Outcome | 2015 |
4 other study(ies) available for omeprazole and lafutidine
| Article | Year |
|---|---|
Gastroprotective activity of FRG-8813, a novel histamine H2-receptor antagonist, in rats.
Topics: Acetamides; Animals; Anti-Ulcer Agents; Drug Interactions; Gastric Mucosa; Gastrointestinal Motility; Histamine H2 Antagonists; Male; Omeprazole; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 1995 |
A new-generation H2 receptor antagonist: quicker and stronger acid inhibition than proton pump inhibitors in the clinical setting?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Benzimidazoles; Gastric Acid; Gastric Acidity Determination; Heartburn; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Omeprazole; Piperidines; Prognosis; Proton Pump Inhibitors; Pyridines; Rabeprazole; Severity of Illness Index; Treatment Outcome | 2005 |
Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Animals; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Fluorouracil; Gastric Mucosa; Gastrointestinal Diseases; Intestinal Mucosa; Lansoprazole; Male; Mucins; Mucositis; Omeprazole; Piperidines; Pyridines; Rats; Rats, Wistar | 2008 |
Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
Topics: 16,16-Dimethylprostaglandin E2; Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Capsaicin; Cimetidine; Disease Models, Animal; Enterobacteriaceae; Famotidine; Histamine H2 Antagonists; Intestinal Mucosa; Intestine, Small; Male; Mucin-2; Nitric Oxide Synthase Type II; Omeprazole; Peptic Ulcer; Peroxidase; Phenylpropionates; Piperidines; Proton Pump Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sensory Receptor Cells | 2010 |